Perspectives in viral clearance
Since the 1990s, viral clearance (VC) studies have been a critical safety step for biologic drugs.
RFK Jr revives childhood vaccine task force
HHS Secretary Kennedy adds yet another layer of scrutiny to childhood vaccines with the re-establishment of a task force disbanded in the 1990s.
AI could lead to 'golden age' of antibiotics
Generative artificial intelligence could hold the key to turning back the rising tide of antimicrobial resistance, say MIT researchers.
FDA clears Precigen's rare tumour immunotherapy
Precigen has won approval in the US for a first-in-class immunotherapy for recurrent respiratory papillomatosis, Papzimeos, its first product.
Featured Content
Editor's Picks
Editor's Picks
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
7th TIL Therapies Summit
Driving the Next Generation of TIL Therapies for Solid Tumors
3rd Donor Selection & Cell Source Summit
Transforming Off-The-Shelf Therapies From the Start
LEAP TA: Life Sciences
Reimagine Hiring Tactics to Compete for the Best Life Sciences Talent
MASH Drug Development Summit
Advancing Efficacious MASH Therapeutics in the Evolving Metabolic Landscape
2nd World Companion Diagnostics & Liquid Biopsy Summit APAC
The Asia-Pacific region is becoming a rising player in the co-development and commercialization of drug-diagnostic strategies